Viral Infections and Different Cancers

Nearly 20% of worldwide cancers, encompassing millions of individuals, stem from viral infections. The human T-cell leukemia virus type 1 (HTLV-1), the human herpes virus 8 (HHV-8), the Epstein-Barr virus (EBV) which is associated with nasopharyngeal carcinoma and Burkitt’s lymphoma, the hepatitis C virus (HCV), the hepatitis B virus (HBV), and the human papillomavirus (HPV), which is a major cause of cervical cancer, are just a few of the seven viruses that have been conclusively concomitant with oncogenesis. These viral foes, despite their limited genetic repertoire, exploit sophisticated mechanisms to manipulate crucial cellular pathways. They hijack processes like cell growth (e.g., through E7 oncoprotein in HPV), differentiation (e.g., by disrupting pRB tumor suppressor), and evasion of the host immune system. Sentinel systems monitor these cellular activities and make sure that abnormal cells are eliminated from the pool of proliferating cells. These regulations are governed via complex, redundant regulatory networks. Viruses that want to be packaged within infectious structures have to target cellular regulatory nodes with little redundancy and deactivate the surveillance mechanisms that normally detect and remove these abnormal cells since they have to fit into relatively small genomes. These regulations governed via highly intricate regulatory networks, with built-in redundancy. To fit into their packaging, viruses must target crucial cellular control points with minimal redundancy, effectively disabling the body’s ability to detect and eliminate these rogue cells. Important proteins within these similar regulatory networks are frequently mutated in malignancies and illnesses that are not virally related. Oncogenic viruses have been instrumental in unraveling cellular control networks. These insights include identifying genes that promote cancer and those that prevent it, understanding pathways crucial for maintaining healthy DNA, and elucidating the processes by which the immune system identifies and eliminates abnormal cells. Viruses employ diverse strategies throughout the multistep process of carcinogenesis, from initiating mutations through integration and DNA damage to hijacking cellular processes and evading immune defenses. This chapter delves into these mechanisms explored through cell culture, animal models, and molecular analyses, providing insights into the complex journey from viral infection to cancer development.